r-Lung-SARS-CoV-2 model by zPREDICTA

Manufacturer zPREDICTA
A human 3D airway screening platform to identify agents with antiviral activity.


r-Lung-SARS-CoV-2 model by zPREDICTA product image
r-Lung-SARS-CoV-2 model

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.



0 Scientists have reviewed this product


Write the First Review

No Reviews

A human 3D airway screening platform to identify agents with antiviral activity.

This platform is based on zPREDICTA’s tissue reconstruction technology that incorporates the tissue-specific extracellular matrix (ECM) and cellular components to replicate the tissue architecture and its biology outside the human body.

Characteristics of zPREDICTA’s r-Lung-SARS-CoV-2 model:

  • Air-liquid interphase (ALI): mimics human airway architecture
  • r-Lung ECM: ECM reconstructing the microenvironment of the human alveolar space
  • Interstitial ECM: ECM reconstructing the microenvironment of the interstitial space
  • Ciliated epithelium: airway cells connected by tight junctions into an epithelial sheet with cilia formed on the apical surface (facing the air compartment); once formed, these ciliated epithelial cells express human ACE2 receptors
  • Interstitial fibroblasts: stromal fibroblasts found in the interstitial space
  • Inflammatory/immune compartment: immune cells capable of mounting an inflammatory response